| 000 | 01515 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513184950.0 | ||
| 264 | 0 | _c19990716 | |
| 008 | 199907s 0 0 eng d | ||
| 022 | _a0009-9147 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aArranz, J A | |
| 245 | 0 | 0 |
_aOptimization of allopurinol challenge: sample purification, protein intake control, and the use of orotidine response as a discriminative variable improve performance of the test for diagnosing ornithine carbamoyltransferase deficiency. _h[electronic resource] |
| 260 |
_bClinical chemistry _cJul 1999 |
||
| 300 |
_a995-1001 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAllopurinol |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 | _aChromatography, Ion Exchange |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOrnithine Carbamoyltransferase Deficiency Disease |
| 650 | 0 | 4 |
_aOrotic Acid _xurine |
| 650 | 0 | 4 |
_aProteins _xadministration & dosage |
| 650 | 0 | 4 | _aROC Curve |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 |
_aUridine _xanalogs & derivatives |
| 700 | 1 | _aRiudor, E | |
| 700 | 1 | _aRodés, M | |
| 700 | 1 | _aRoig, M | |
| 700 | 1 | _aCliment, C | |
| 700 | 1 | _aRubio, V | |
| 700 | 1 | _aSentís, M | |
| 700 | 1 | _aBurlina, A | |
| 773 | 0 |
_tClinical chemistry _gvol. 45 _gno. 7 _gp. 995-1001 |
|
| 999 |
_c10346814 _d10346814 |
||